SBRA vs AHR vs JAN Stock Comparison

Sabra Health Care REIT, American Healthcare REIT and Janus Living Prices as of Nov 13, 2026 Peers: Industry group
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.25B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
–
Healthcare REITs Real Estate

Head to Head

10 decided of 12

Sabra Health Care REIT leads on 7 of the 12 questions below (Sabra Health Care REIT 7, American Healthcare REIT 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSBRAAHRJANLeader
Larger companyMarket capitalisation $5.20B $12.58B $7.25B AHR
Cheaper on earningsLower P/E, profitable companies only 72.7x 130.6x -3,357x SBRA
Cheaper on forward earningsLower price / next fiscal year consensus EPS 53.8x 91.7x 318.2x SBRA
Faster revenue growthRevenue growth, trailing twelve months +23.4% +21.5% — SBRA
More profitableNet margin, trailing twelve months 7.8% 3.6% -0.3% SBRA
Better return on capitalReturn on invested capital 4.4% -31.7% -21.2% SBRA
Less leveragedLower net debt / EBITDA 2.9x -0.7x — AHR
Higher dividend yieldTrailing dividend yield -0.06% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months +9.4% +19.8% — AHR
Better 5-year returnAnnualised price return, 5 years +6.7%/yr — — –
Less volatileAnnualised volatility, 1 year 24.8% 26.6% 28.9% SBRA
Higher overall scoreMean of the five percentile scores vs peers 50/100 44/100 25/100 SBRA

Percentile Scorecard

SBRAAHRJAN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSBRAAHRJAN
Valuation 40 #90 of 149 5 #141 of 149 1 #147 of 149
Growth 51 #73 of 147 86 #22 of 147 –
Profitability 56 #64 of 144 25 #109 of 144 26 #107 of 144
Financial Health 85 #24 of 149 84 #25 of 149 72 #43 of 149
Shareholder Returns 17 #115 of 139 22 #109 of 139 2 #136 of 139
Overall 50 44 25
  • SBRA ranked among 150 companies in Property REITs
  • AHR ranked among 150 companies in Property REITs
  • JAN ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSBRAAHRJANSPY
1 month +6.6%+10.2%+9.8% -2.0%
3 months +0.6%+6.4%+3.9% -2.8%
6 months -1.1%+17.1%+19.3% +2.0%
Year to date +7.9%+22.8%— +10.6%
1 year +9.4%+19.8%— +12.2%
3 years +40.5%—— +68.1%
3 years, per year +12.0%—— +18.9%
5 years +38.6%—— +61.4%
5 years, per year +6.7%—— +10.1%
10 years -0.2%—— +248.5%
10 years, per year 0.0%—— +13.3%

Risk

MeasureSBRAAHRJANSPY
Volatility, 1Y 24.8%26.6%28.9% 13.6%
Downside volatility, 1Y 22.5%27.3%26.9% 13.9%
Beta vs S&P 500, 1Y -0.130.05-0.01 1.00
Return / volatility, 1Y 0.380.74— 0.90
Max drawdown, 5Y -38.7%-14.5%-13.8% -25.4%
From 52-week high -8.7%-2.7%-3.2% -3.2%
52-week high $22.39$59.40$32.88 $779.14
52-week low $17.67$45.69$22.88 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSBRAAHRJAN
P/E now vs peer median 73.1xmedian 26.1x 130.1xmedian 26.1x -3,327xmedian 26.1x
P/S now vs peer median 5.8xmedian 4.3x 5.0xmedian 4.3x 8.9xmedian 4.3x
EV/EBITDA now vs peer median 15.7xmedian 14.5x -9.3xmedian 14.5x -10.9xmedian 14.5x
P/FCF now vs peer median -16.4xmedian 21.4x -20.2xmedian 21.4x -3.5xmedian 21.4x
P/B now vs peer median 1.9xmedian 1.2x 2.4xmedian 1.2x 1.8xmedian 1.2x
PEG now vs peer median 1.85median 1.75 4.02median 1.75 —median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSBRAAHRJAN
Revenue $919.09M $2.67B $835.56M
Gross profit – $589.22M –
Operating income – -$1.92B -$871.49M
Net income $71.46M $97.45M $38.54M
Free cash flow -$325.53M -$662.56M -$2.15B
EPS (diluted) $0.28 $0.44 $-0.01
Cash & equivalents $36.24M $258.67M $338.06M
Total debt $1.36B $1.36B –
Shares (diluted) 259.82M 217.71M 225.97M
Enterprise value $4.75B $11.82B $4.39B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSBRAAHRJAN
P/E 73.1x 130.1x -3,327x
P/FCF -16.4x -20.2x -3.5x
P/Operating cash flow 13.4x 31.8x 30.0x
P/S 5.8x 5.0x 8.9x
P/B 1.9x 2.4x 1.8x
P/Tangible book 1.9x 2.6x 2.0x
EV/EBITDA 15.7x -9.3x -10.9x
EV/EBIT 36.1x -7.6x -8.2x
EV/Revenue 7.1x 5.4x 8.5x
EV/FCF -20.1x -21.9x -3.3x
EV/Operating cash flow 16.4x 34.4x 28.7x
PEG (3Y EPS CAGR) 1.85 4.02 –

Growth

14 metrics
MetricSBRAAHRJAN
Revenue growth (1Y) 23.4% 21.5% –
Revenue CAGR (3Y) 12.3% 16.8% –
Gross profit growth (1Y) – 29.5% –
Gross profit CAGR (3Y) – 43.5% –
Operating income growth (1Y) – -21.6% –
Operating income CAGR (3Y) – -6.8% –
Net income growth (1Y) -59.2% 255.0% –
Net income CAGR (3Y) 41.1% 44.8% –
EPS growth (1Y) -61.7% 175.6% –
EPS CAGR (3Y) 39.6% 32.4% –
Operating cash flow growth (1Y) 17.4% 41.2% –
Operating cash flow CAGR (3Y) 11.4% 57.9% –
Free cash flow growth (1Y) -1,239% -1,027% –
Free cash flow CAGR (3Y) -59.7% -114.2% –

Profitability

14 metrics
MetricSBRAAHRJAN
Gross margin – 22.1% –
EBITDA margin 45.3% -58.3% -78.3%
Operating margin – -71.8% -104.3%
Pretax margin 7.1% 3.6% 4.7%
Net margin 7.8% 3.6% -0.3%
FCF margin -35.4% -24.8% -257.6%
Operating cash flow margin 43.6% 15.8% 29.7%
Return on equity 2.5% 2.1% 1.0%
Return on assets 1.3% 1.5% 0.8%
Return on invested capital 4.4% -31.7% -21.2%
Return on capital employed – – –
Asset turnover 0.2x 0.4x 0.2x
Cash conversion (OCF / net income) 5.6x 4.3x 6.4x
Stock comp / revenue 1.5% 0.9% 0.1%

Financial Health

11 metrics
MetricSBRAAHRJAN
Debt / assets 22.8% 17.9% –
Debt / equity 0.4x 0.2x –
Net debt / EBITDA 2.9x -0.7x –
Debt / FCF -3.8x -2.1x –
Liabilities / assets 47.7% 26.6% 21.0%
Equity / assets 52.3% 73.4% 79.0%
Interest coverage 1.6x -25.6x -407.8x
Current ratio – – –
Quick ratio – – –
Cash ratio – – –
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricSBRAAHRJAN
Dividend yield 7.3% 1.7% 1.3%
Net buyback yield -3.8% -22.2% -11.2%
Shareholder yield 3.5% -20.5% -9.9%
Payout ratio (earnings) 423.7% 190.9% –
Payout ratio (FCF) -93.0% -28.1% –
Dividend growth (1Y) -6.0% 17.0% –
Dividend CAGR (3Y) -3.0% 35.1% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSBRAAHRJAN
Forward P/E 53.8xFY2026 91.7xFY2026 318.2xFY2026
EPS, next fiscal year $0.38FY2026 $0.63FY2026 $0.10FY2026
EPS growth, next FY -40.6%FY2026 +50.0%FY2026 +150.0%FY2026
EPS growth, the year after +94.7% +36.5% -10.0%
Revenue, next fiscal year $882.92MFY2026 $2.65BFY2026 $885.94MFY2026
Revenue growth, next FY +14.0%FY2026 +17.1%FY2026 +27.8%FY2026
Revenue growth, the year after +14.4% +29.9% +42.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSBRAAHRJAN
Held by institutions 100.0% 100.0% 38.1%
Institutions holding 464 573 162
Change in shares held, QoQ +0.7% +19.9% +56.8%
Institutions buying 229 335 137
Institutions selling 147 165 19
Buyers to sellers 1.56 2.03 7.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SBRAAHRJAN
SBRA 1.00 0.64 0.54
AHR 0.64 1.00 0.60
JAN 0.54 0.60 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SBRA, AHR and JAN?

American Healthcare REIT (AHR) is the largest by market capitalisation: Sabra Health Care REIT (SBRA) $5.20B, American Healthcare REIT (AHR) $12.58B, Janus Living (JAN) $7.25B.

Which stock is cheaper, SBRA, AHR and JAN?

Sabra Health Care REIT (SBRA) trades on the lowest price-to-earnings ratio (Sabra Health Care REIT (SBRA) 72.7x, American Healthcare REIT (AHR) 130.6x, Janus Living (JAN) -3,357x). On next year's consensus earnings, Sabra Health Care REIT (SBRA) is cheapest (Sabra Health Care REIT (SBRA) 53.8x, American Healthcare REIT (AHR) 91.7x, Janus Living (JAN) 318.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Sabra Health Care REIT (SBRA) grew revenue fastest over the trailing twelve months: Sabra Health Care REIT (SBRA) +23.4%, American Healthcare REIT (AHR) +21.5%.

Which company is more profitable?

Sabra Health Care REIT (SBRA) has the highest net margin (Sabra Health Care REIT (SBRA) 7.8%, American Healthcare REIT (AHR) 3.6%, Janus Living (JAN) -0.3%). On return on invested capital, Sabra Health Care REIT (SBRA) leads (Sabra Health Care REIT (SBRA) 4.4%, American Healthcare REIT (AHR) -31.7%, Janus Living (JAN) -21.2%).

Which stock has performed better?

Over the past year American Healthcare REIT (AHR) returned the most: Sabra Health Care REIT (SBRA) +9.4%, American Healthcare REIT (AHR) +19.8%. Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Sabra Health Care REIT (SBRA) -0.06%, American Healthcare REIT (AHR) 0.01%, Janus Living (JAN) 0.00%. Sabra Health Care REIT (SBRA) and Janus Living (JAN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Sabra Health Care REIT (SBRA) has been the steadiest (Sabra Health Care REIT (SBRA) 24.8%, American Healthcare REIT (AHR) 26.6%, Janus Living (JAN) 28.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SBRA, AHR and JAN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Sabra Health Care REIT (SBRA) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.